Shengbao Li

500 total citations
30 papers, 381 citations indexed

About

Shengbao Li is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Shengbao Li has authored 30 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 11 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Shengbao Li's work include Esophageal Cancer Research and Treatment (6 papers), Gastroesophageal reflux and treatments (4 papers) and Gastric Cancer Management and Outcomes (4 papers). Shengbao Li is often cited by papers focused on Esophageal Cancer Research and Treatment (6 papers), Gastroesophageal reflux and treatments (4 papers) and Gastric Cancer Management and Outcomes (4 papers). Shengbao Li collaborates with scholars based in China and United States. Shengbao Li's co-authors include Qiang Tong, Shu Jin, Xiaobo Liu, Qingming Wu, Hui Long, Ren Zhang, Wanxin Liu, Fei Yao, Weiguo Hu and Huan Li and has published in prestigious journals such as Scientific Reports, World Journal of Gastroenterology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Shengbao Li

27 papers receiving 375 citations

Peers

Shengbao Li
Shengbao Li
Citations per year, relative to Shengbao Li Shengbao Li (= 1×) peers Xiaosun Liu

Countries citing papers authored by Shengbao Li

Since Specialization
Citations

This map shows the geographic impact of Shengbao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengbao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengbao Li more than expected).

Fields of papers citing papers by Shengbao Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengbao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengbao Li. The network helps show where Shengbao Li may publish in the future.

Co-authorship network of co-authors of Shengbao Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shengbao Li. A scholar is included among the top collaborators of Shengbao Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengbao Li. Shengbao Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liu, Xiaobo, et al.. (2024). TET2 Is Downregulated in Early Esophageal Squamous Cell Carcinoma and Promotes Esophageal Squamous Cell Malignant Behaviors. Digestive Diseases and Sciences. 69(7). 2462–2476. 1 indexed citations
3.
Wang, Maoli, et al.. (2023). PhishHunter: Detecting camouflaged IDN-based phishing attacks via Siamese neural network. Computers & Security. 138. 103668–103668. 4 indexed citations
4.
Pan, Jun, et al.. (2023). Identification of RNF150 as the hub gene associated with microsatellite instability in gastric cancer. Scientific Reports. 13(1). 12495–12495.
5.
Li, Shengbao, et al.. (2023). FusionTC: Encrypted App Traffic Classification Using Decision-Level Multimodal Fusion Learning of Flow Sequence. Wireless Communications and Mobile Computing. 2023. 1–15. 2 indexed citations
6.
Tan, Niandi, Xin-Pu Miao, Chengxia Liu, et al.. (2023). Efficacy and Safety of Keverprazan Compared With Lansoprazole in the Treatment of Duodenal Ulcer: A Phase III, Randomized, Double-Blind, Multicenter Trial. Clinical and Translational Gastroenterology. 14(7). e00602–e00602. 10 indexed citations
7.
Chen, Songfeng, Deliang Liu, Honghui Chen, et al.. (2022). The efficacy and safety of keverprazan, a novel potassium‐competitive acid blocker, in treating erosive oesophagitis: a phase III, randomised, double‐blind multicentre study. Alimentary Pharmacology & Therapeutics. 55(12). 1524–1533. 30 indexed citations
8.
Liu, Xiaobo, et al.. (2020). Clinicopathological features of esophageal schwannomas in mainland China: systematic review of the literature. International Journal of Clinical Oncology. 26(2). 284–295. 5 indexed citations
9.
Liu, Wanxin, Ren Zhang, Huan Li, et al.. (2020). Study of the Relationship between Microbiome and Colorectal Cancer Susceptibility Using 16SrRNA Sequencing. BioMed Research International. 2020(1). 7828392–7828392. 106 indexed citations
11.
Liu, Xiaobo, et al.. (2019). <p>Serum pepsinogen assay is not recommended for the diagnosis of esophageal squamous cell carcinoma: a systematic review and meta-analysis</p>. Cancer Management and Research. Volume 11. 5643–5654. 3 indexed citations
13.
Wang, Yan, Shu Jin, Weiping Deng, et al.. (2012). Up-regulation of P-glycoprotein is involved in the increased paclitaxel resistance in human esophageal cancer radioresistant cells. Scandinavian Journal of Gastroenterology. 47(7). 802–808. 28 indexed citations
14.
Li, Shengbao, Dean Tian, Fei Pei, et al.. (2011). A Cyclooxygase-2 Inhibitor NS-398-Enhanced Apoptosis of Esophageal Carcinoma Cell EC9706 by Adjusting Expression of Survivin and Caspase-3. Cancer Investigation. 29(2). 102–106. 3 indexed citations
15.
Zhang, Weiguo, Qiang Tong, Zihua Chen, et al.. (2010). The usefulness of endoscopic ultrasound in the differential diagnosis between benign and malignant gastric ulcer. Scandinavian Journal of Gastroenterology. 45(9). 1093–1096. 2 indexed citations
16.
Zhang, Weiguo, Qiang Tong, Qingming Wu, et al.. (2009). Upregulated p27kip1 can Downregulate Survivin Expression and Inhibit Telomerase Activity in Gastric Carcinoma Cells. Cancer Investigation. 27(9). 898–900. 7 indexed citations
17.
Zhang, Weiguo, et al.. (2009). T lymphocyte Subsets Determination and DNA Ploidy Analysis in the Differential Diagnosis between Benign and Malignant Ascites. Cancer Investigation. 27(1). 67–69. 2 indexed citations
18.
Li, Shengbao, et al.. (2008). Mechanism of Growth Inhibitory Effects of Cyclooxygenase-2 Inhibitor–NS398 on Cancer Cells. Cancer Investigation. 26(4). 333–337. 13 indexed citations
19.
Zhang, Weiguo, Qiang Tong, Shengbao Li, Xiaohu Wang, & Qiang Wang. (2008). MG-132 Inhibits Telomerase Activity, Induces Apoptosis and G1Arrest Associated with Upregulated p27kip1 Expression and Downregulated Survivin Expression in Gastric Carcinoma Cells. Cancer Investigation. 26(10). 1032–1036. 20 indexed citations
20.
Wang, Qiang, Qingming Wu, & Shengbao Li. (2000). Detection of telomerase activity and cytology in diagnosis of cardiac cancer. World Journal of Gastroenterology. 6. 46–46. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026